Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(0)
# 4444
Out of 5,337 analysts
12
Total ratings
41.67%
Success rate
-12.86%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ITOS ITeos Therapeutics | Maintains: Overweight | 16 13 | 8.01 | 62.3% | 5 | May 14, 2025 | |
MRUS Merus | Maintains: Overweight | 91 89 | 40.3 | 120.84% | 1 | May 8, 2025 | |
RCUS Arcus Biosciences | Maintains: Overweight | 29 26 | 8.49 | 206.24% | 2 | May 7, 2025 | |
BCAX Bicara Therapeutics | Initiates Coverage On: Underweight | 8 | 13.63 | -41.31% | 1 | Apr 17, 2025 | |
XNCR Xencor | Maintains: Overweight | 37 33 | 8.05 | 309.94% | 2 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 34 | 25.27 | 34.55% | 1 | May 3, 2024 |